Skip to content

Study to check the efficacy of Panchakarma procedures in the management of Multiple sclerosis

A Pilot Study to evaluate the Clinical Efficacy of an Ayurvedic Treatment Module in the Management of Multiple Sclerosis ( Sarvanga Gatavata) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064562
Enrollment
15
Registered
2024-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G35- Multiple sclerosis

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are fit to undergo Snehapana, Virechana, Swedana,Basti and Nasya Karma. 2.Diagnosed cases of Multiple Sclerosis with MRI , continuing allopathic medication and EDSS score less than 8. 3. ICD code: G - 35 4. Socio- economic status: All

Exclusion criteria

Exclusion criteria: 1. Cardiac disease, pulmonary tuberculosis, severe lung disease, diabetes and pregnant women, exposed skin related disease. 2.EDSS score more than 8 .

Design outcomes

Primary

MeasureTime frame
Reduction in spasticity using MSSS 88 SCALE. Timepoint: (Day-0) (Day-22) (Day-38) (Day-52)

Secondary

MeasureTime frame
To determine the change in Quality of life using MSQL54 instrument, Visual Analog score and EDSS. Timepoint: (Day-0) (Day-22) (Day-38) (Day-52)

Countries

India

Contacts

Public ContactProfDr Anandaraman PV

All India Institute of Ayurveda

drprasanthd@gmail.com9895174060

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026